Key result
AF is not linked to worsened cerebrovascular function compared to healthy controls.
Why the study?
AF is associated with stroke, cognitive decline, and dementia, but whether it worsens cerebrovascular function evaluated via neurovascular coupling and cerebrovascular carbon dioxide reactivity was unclear.
Does atrial fibrillation worsen cerebrovascular function as evaluated by neurovascular coupling and cerebrovascular carbon dioxide reactivity compared to healthy controls?
Cross-Sectional (n=39)
Does atrial fibrillation worsen cerebrovascular function as evaluated by neurovascular coupling and cerebrovascular carbon dioxide reactivity compared to healthy controls?
Absolute Event Rate: 3.23% vs 3.09%
p-value: p=0.513
Neurovascular coupling and cerebrovascular carbon dioxide reactivity responses appear preserved in patients with atrial fibrillation compared to healthy controls, despite lower relative hippocampal volumes.
Should not change AF management; leaves open longitudinal or subgroup effects on cerebrovascular reactivity.
Atrial fibrillation (AF) is associated with a high risk of stroke, as well as cognitive decline and dementia. Advanced imaging techniques were employed to test the hypothesis that AF worsens cerebrovascular function as evaluated using neurovascular coupling (NVC) and cerebrovascular carbon dioxide reactivity (CVR CO2 ) tests. Twenty healthy controls (HC; 63.4±9.5 years) and nineteen AF patients (66.6±12.0 years) completed NVC (visual stimulation with a flickering checkerboard) and CVR CO2 (5%CO 2 ) assessments during functional (blood oxygen level-dependent [BOLD]) and perfusion (arterial spin labelling) magnetic resonance imaging. Additionally, brain volumes and cognition were assessed. During CVR CO2 assessment, neither %∆ in BOLD signal (HC: 3.09±0.50; AF: 3.23±0.70%; p =0.513) nor %∆ in cerebral blood flow (CBF) (HC: 36.6±18.8; AF: 43.6±20.6%; p =0.319) were different between groups. During NVC assessment, CMRO 2 (HC: 5.25±1.84; AF: 4.36±2.50%, p =0.285), %∆BOLD (HC: 1.60±0.38; AF: 1.66±0.79%; p =0.762) and %∆CBF (HC: 49.4 [20.1-71.9]; AF: 51.7 [38.3-66.9]%; p =0.850) all increased similarly in HC and AF. AF patients had lower hippocampal volume relative to total intracranial volume than HC (0.50±0.06 vs. 0.55±0.06%; p =0.020). There were no differences between HC and AF in cognitive performance across multiple domains (all p >0.05). These results suggest that NVC and CVR CO2 responses are preserved in AF.
No takes yet. Share an insight, caveat, or question.
Walsh et al. (2026) conducted a cross-sectional in Atrial Fibrillation (n=39). Atrial fibrillation vs. Healthy controls was evaluated on Cerebrovascular carbon dioxide reactivity (%∆ in BOLD signal) (p=0.513). Atrial fibrillation was not associated with worsened cerebrovascular function, as %∆ in BOLD signal during CVR CO2 was similar between AF patients and healthy controls (3.23% vs 3.09%; p=0.513).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: